Hydrogen sulfide protects blood-brain barrier integrity following cerebral ischemia

Journal of Neurochemistry

Volumn 129, Issue 5, 2014, Pages 827-838

  Wang, Yali ^a,b   Jia, Jia ^a   Ao, Guizhen ^a   Hu, Lifang ^a   Liu, Hui ^a   Xiao, Yunqi ^a   Du, Huaping ^a   Alkayed, Nabil J ^c   Liu, Chun Feng ^a,b   Cheng, Jian ^a,b  

^a SOOCHOW UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Blood brain barrier; cerebral ischemia; hydrogen sulfide; vasoprotection

Indexed keywords

5 (4 METHOXYPHENYL) 3H 1 2 DITHIOLE 3 THIONE; ARGINASE 1; EVANS BLUE; GELATINASE B; HYDROGEN SULFIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 1BETA; MESSENGER RNA; NEUROPROTECTIVE AGENT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TIGHT JUNCTION PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN DAMAGE; BRAIN EDEMA; BRAIN INFARCTION; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG MECHANISM; ENCEPHALITIS; ENZYME ACTIVITY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

MUS;

BLOOD-BRAIN BARRIER; CEREBRAL ISCHEMIA; HYDROGEN SULFIDE; VASOPROTECTION;

ANIMALS; BEHAVIOR, ANIMAL; BLOOD-BRAIN BARRIER; BLOTTING, WESTERN; BRAIN EDEMA; BRAIN ISCHEMIA; COLORING AGENTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EVANS BLUE; HYDROGEN SULFIDE; INFARCTION, MIDDLE CEREBRAL ARTERY; INTERLEUKIN-10; MALE; MICE; MICE, INBRED ICR; NADPH OXIDASE; NEUROPROTECTIVE AGENTS; NF-KAPPA B; PEROXIDASE; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84901193671     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12695     Document Type: Article

References (53)

1. Asahi M., Wang X., Mori T., Sumii T., Jung J. C., Moskowitz M. A., Fini M. E., and, Lo E. H., (2001) Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J. Neurosci. 21, 7724-7732.
2. Bos E. M., Wang R., Snijder P. M., et al,. (2013) Cystathionine gamma-lyase protects against renal ischemia/reperfusion by modulating oxidative stress. J. Am. Soc. Nephrol. 24, 759-770.
3. Brancaleone V., Roviezzo F., Vellecco V., De Gruttola L., Bucci M., and, Cirino G., (2008) Biosynthesis of H2S is impaired in non-obese diabetic (NOD) mice. Br. J. Pharmacol. 155, 673-680.
4. Chen J. W., Breckwoldt M. O., Aikawa E., Chiang G., and, Weissleder R., (2008) Myeloperoxidase-targeted imaging of active inflammatory lesions in murine experimental autoimmune encephalomyelitis. Brain 131, 1123-1133.
5. Ding Y., Liu D., Liu Y., Xie B., Liu Z., and, Zhang D., (2008) Pharmacokinetics and bioequivalence of anethol trithione in Chinese healthy volunteers. Chin. Pharm. J. 43, 929-932.
6. ElAli A., Doeppner T. R., Zechariah A., and, Hermann D. M., (2011) Increased blood-brain barrier permeability and brain edema after focal cerebral ischemia induced by hyperlipidemia: role of lipid peroxidation and calpain-1/2, matrix metalloproteinase-2/9, and RhoA overactivation. Stroke 42, 3238-3244.
7. Elrod J. W., Calvert J. W., Morrison J., et al,. (2007) Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc. Natl Acad. Sci. USA 104, 15560-15565.
8. Fagan S. C., Lapchak P. A., Liebeskind D. S., Ishrat T., and, Ergul A., (2013) Recommendations for preclinical research in hemorrhagic transformation. Transl. Stroke Res. 4, 322-327.
9. Florian B., Vintilescu R., Balseanu A. T., Buga A. M., Grisk O., Walker L. C., Kessler C., and, Popa-Wagner A., (2008) Long-term hypothermia reduces infarct volume in aged rats after focal ischemia. Neurosci. Lett. 438, 180-185.
10. Gu X., and, Zhu Y. Z., (2011) Therapeutic applications of organosulfur compounds as novel hydrogen sulfide donors and/or mediators. Expert Rev. Clin. Pharmacol. 4, 123-133.
11. Hacke W., Schwab S., Horn M., Spranger M., De Georgia M., and, von Kummer R., (1996) 'Malignant' middle cerebral artery territory infarction: clinical course and prognostic signs. Arch. Neurol. 53, 309-315.
12. Hu L. F., Lu M., Hon Wong P. T., and, Bian J. S., (2011) Hydrogen sulfide: neurophysiology and neuropathology. Antioxid. Redox Signal. 15, 405-419.
13. Hu X., Li P., Guo Y., Wang H., Leak R. K., Chen S., Gao Y., and, Chen J., (2012) Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke 43, 3063-3070.
14. Huang J., Li Y., Tang Y., Tang G., Yang G. Y., and, Wang Y., (2013) CXCR4 antagonist AMD3100 protects blood-brain barrier integrity and reduces inflammatory response after focal ischemia in mice. Stroke 44, 190-197.
15. Hunter J. P., Hosgood S. A., Patel M., Rose R., Read K., and, Nicholson M. L., (2012) Effects of hydrogen sulphide in an experimental model of renal ischaemia-reperfusion injury. Br. J. Surg. 99, 1665-1671.
16. Infanger D. W., Sharma R. V., and, Davisson R. L., (2006) NADPH oxidases of the brain: distribution, regulation, and function. Antioxid. Redox Signal. 8, 1583-1596.
17. Jia J., Xiao Y., Wang W., Qing L., Xu Y., Song H., Zhen X., Ao G., Alkayed N. J., and, Cheng J., (2013) Differential mechanisms underlying neuroprotection of hydrogen sulfide donors against oxidative stress. Neurochem. Int. 62, 1072-1078.
18. Kahles T., Luedike P., Endres M., Galla H. J., Steinmetz H., Busse R., Neumann-Haefelin T., and, Brandes R. P., (2007) NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke. Stroke 38, 3000-3006.
19. Khan M., Dhammu T. S., Sakakima H., Shunmugavel A., Gilg A. G., Singh A. K., and, Singh I., (2012) The inhibitory effect of S-nitrosoglutathione on blood-brain barrier disruption and peroxynitrite formation in a rat model of experimental stroke. J. Neurochem. 123 (Suppl 2), 86-97.
20. Kim G. W., Gasche Y., Grzeschik S., Copin J. C., Maier C. M., and, Chan P. H., (2003) Neurodegeneration in striatum induced by the mitochondrial toxin 3-nitropropionic acid: role of matrix metalloproteinase-9 in early blood-brain barrier disruption? J. Neurosci. 23, 8733-8742.
21. Kristian T., and, Hu B., (2013) Guidelines for using mouse global cerebral ischemia models. Transl. Stroke Res. 4, 343-350.
22. Lakhan S. E., Kirchgessner A., Tepper D., and, Leonard A., (2013) Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke. Front. Neurol. 4, 32.
23. Lee M., Tazzari V., Giustarini D., Rossi R., Sparatore A., Del Soldato P., McGeer E., and, McGeer P. L., (2010) Effects of hydrogen sulfide-releasing L-DOPA derivatives on glial activation: potential for treating Parkinson disease. J. Biol. Chem. 285, 17318-17328.
24. Li L., Whiteman M., Guan Y. Y., Neo K. L., Cheng Y., Lee S. W., Zhao Y., Baskar R., Tan C. H., and, Moore P. K., (2008) Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide. Circulation 117, 2351-2360.
25. Li G. F., Luo H. K., Li L. F., Zhang Q. Z., Xie L. J., Jiang H., Li L. P., Hao N., Wang W. W., and, Zhang J. X., (2012) Dual effects of hydrogen sulphide on focal cerebral ischaemic injury via modulation of oxidative stress-induced apoptosis. Clin. Exp. Pharmacol. Physiol. 39, 765-771.
26. Liu W., Sood R., Chen Q., Sakoglu U., Hendren J., Cetin O., Miyake M., and, Liu K. J., (2008) Normobaric hyperoxia inhibits NADPH oxidase-mediated matrix metalloproteinase-9 induction in cerebral microvessels in experimental stroke. J. Neurochem. 107, 1196-1205.
27. Liu W., Hendren J., Qin X. J., Shen J., and, Liu K. J., (2009) Normobaric hyperoxia attenuates early blood-brain barrier disruption by inhibiting MMP-9-mediated occludin degradation in focal cerebral ischemia. J. Neurochem. 108, 811-820.
28. Lu Q., Xia N., Xu H., Guo L., Wenzel P., Daiber A., Munzel T., Forstermann U., and, Li H., (2011) Betulinic acid protects against cerebral ischemia-reperfusion injury in mice by reducing oxidative and nitrosative stress. Nitric Oxide 24, 132-138.
29. Marutani E., Kosugi S., Tokuda K., Khatri A., Nguyen R., Atochin D. N., Kida K., Van Leyen K., Arai K., and, Ichinose F., (2012) A novel hydrogen sulfide-releasing N-methyl-D-aspartate receptor antagonist prevents ischemic neuronal death. J. Biol. Chem. 287, 32124-32135.
30. Masoud A. N., and, Bueding E., (1983) Identification and quantitation of a metabolite of anethol dithiolthione in rat and mouse urine using high-performance liquid chromatography. J. Chromatogr. 276, 111-119.
31. McCullough L. D., Tarabishy S., Liu L., Benashski S., Xu Y., Ribar T., Means A., and, Li J., (2013) inhibition of calcium/calmodulin-dependent protein kinase kinase beta and calcium/calmodulin-dependent protein kinase IV is detrimental in cerebral ischemia. Stroke 44, 2559-2566.
32. Minamishima S., Bougaki M., Sips P. Y., Yu J. D., Minamishima Y. A., Elrod J. W., Lefer D. J., Bloch K. D., and, Ichinose F., (2009) Hydrogen sulfide improves survival after cardiac arrest and cardiopulmonary resuscitation via a nitric oxide synthase 3-dependent mechanism in mice. Circulation 120, 888-896.
33. Nicholson C. K., Lambert J. P., Molkentin J. D., Sadoshima J., and, Calvert J. W., (2013) Thioredoxin 1 is essential for sodium sulfide-mediated cardioprotection in the setting of heart failure. Arterioscler. Thromb. Vasc. Biol. 33, 744-751.
34. Pillai D. R., Shanbhag N. C., Dittmar M. S., Bogdahn U., and, Schlachetzki F., (2013) Neurovascular protection by targeting early blood-brain barrier disruption with neurotrophic factors after ischemia-reperfusion in rats(*). J. Cereb. Blood Flow Metab. 33, 557-566.
35. Place R. F., Noonan E. J., and, Giardina C., (2005) HDAC inhibition prevents NF-kappa B activation by suppressing proteasome activity: down-regulation of proteasome subunit expression stabilizes I kappa B alpha. Biochem. Pharmacol. 70, 394-406.
36. Qu K., Chen C. P., Halliwell B., Moore P. K., and, Wong P. T., (2006) Hydrogen sulfide is a mediator of cerebral ischemic damage. Stroke 37, 889-893.
37. Radermacher K. A., Wingler K., Langhauser F., Altenhofer S., Kleikers P., Hermans J. J., Hrabe de Angelis M., Kleinschnitz C., and, Schmidt H. H., (2013) Neuroprotection after stroke by targeting NOX4 as a source of oxidative stress. Antioxid. Redox Signal. 18, 1418-1427.
38. Ren C., Du A., Li D., Sui J., Mayhan W. G., and, Zhao H., (2010) Dynamic change of hydrogen sulfide during global cerebral ischemia-reperfusion and its effect in rats. Brain Res. 1345, 197-205.
39. Rosenberg G. A., (2012) Neurological diseases in relation to the blood-brain barrier. J. Cereb. Blood Flow Metab. 32, 1139-1151.
40. Shimizu H., Saito S., Higashiyama Y., Nishijima F., and, Niwa T., (2013) CREB, NF-kappaB, and NADPH oxidase coordinately upregulate indoxyl sulfate-induced angiotensinogen expression in proximal tubular cells. Am. J. Physiol. Cell Physiol. 304, C685-C692.
41. Suzuki K., Olah G., Modis K., et al,. (2011) Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function. Proc. Natl Acad. Sci. USA 108, 13829-13834.
42. Uchida M., Palmateer J. M., Herson P. S., DeVries A. C., Cheng J., and, Hurn P. D., (2009) Dose-dependent effects of androgens on outcome after focal cerebral ischemia in adult male mice. J. Cereb. Blood Flow Metab. 29, 1454-1462.
43. Ukai Y., Taniguchi N., Takeshita K., Kimura K., and, Enomoto H., (1984) Chronic anethole trithione treatment enhances the salivary secretion and increases the muscarinic acetylcholine receptors in the rat submaxillary gland. Arch. Int. Pharmacodyn. Ther. 271, 206-212.
44. Wang Z., Leng Y., Tsai L. K., Leeds P., and, Chuang D. M., (2011) Valproic acid attenuates blood-brain barrier disruption in a rat model of transient focal cerebral ischemia: the roles of HDAC and MMP-9 inhibition. J. Cereb. Blood Flow Metab. 31, 52-57.
45. Warach S., and, Latour L. L., (2004) Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption. Stroke 35, 2659-2661.
46. Wen Y. D., Wang H., Kho S. H., Rinkiko S., Sheng X., Shen H. M., and, Zhu Y. Z., (2013) Hydrogen sulfide protects HUVECs against hydrogen peroxide induced mitochondrial dysfunction and oxidative stress. PLoS ONE 8, e53147.
47. Whiteman M., and, Winyard P. G., (2011) Hydrogen sulfide and inflammation: the good, the bad, the ugly and the promising. Expert Rev. Clin. Pharmacol. 4, 13-32.
48. Williams C. R., Lu X., Sutliff R. L., and, Hart C. M., (2012) Rosiglitazone attenuates NF-kappaB-mediated Nox4 upregulation in hyperglycemia-activated endothelial cells. Am. J. Physiol. Cell Physiol. 303, C213-C223.
49. Yang G., Zhao K., Ju Y., Mani S., Cao Q., Puukila S., Khaper N., Wu L., and, Wang R., (2013) Hydrogen sulfide protects against cellular senescence via S-sulfhydration of Keap1 and activation of Nrf2. Antioxid. Redox Signal. 18, 1906-1919.
50. Yin J., Tu C., Zhao J., Ou D., Chen G., Liu Y., and, Xiao X., (2013) Exogenous hydrogen sulfide protects against global cerebral ischemia/reperfusion injury via its anti-oxidative, anti-inflammatory and anti-apoptotic effects in rats. Brain Res. 1491, 188-196.
51. Zhang Y., and, Munday R., (2008) Dithiolethiones for cancer chemoprevention: where do we stand? Mol. Cancer Ther. 7, 3470-3479.
52. Zhu Y. Z., Wang Z. J., Ho P., Loke Y. Y., Zhu Y. C., Huang S. H., Tan C. S., Whiteman M., Lu J., and, Moore P. K., (2007) Hydrogen sulfide and its possible roles in myocardial ischemia in experimental rats. J. Appl. Physiol. 102, 261-268.
53. Zhu W., Wang L., Zhang L., Palmateer J. M., Libal N. L., Hurn P. D., Herson P. S., and, Murphy S. J., (2010) Isoflurane preconditioning neuroprotection in experimental focal stroke is androgen-dependent in male mice. Neuroscience 169, 758-769.